|
|
2GO53 |
|
Vaxjo ID |
139 |
|
Vaccine Adjuvant Name |
2GO53 |
|
Adjuvant VO ID |
VO_0006098
|
|
Description |
A vaccine adjuvant, a small molecule TLR agonist that drives a mixed Th1/Th2 response |
|
Stage of Development |
Research |
|
Location Licensed |
United States |
|
Host Species for Testing |
Mouse |
|
Storage |
Formulated material at 4C for 6 months Solid form is stable at 4C for > 2 years |
| References |
(Carson, 2023): Vaccine Adjuvant Compendium [https://vac.niaid.nih.gov/view?id=80]
|
|
